Mohammad Faranoush Selected Research

DAV regimen

12/2015

Family History and Relapse in Pediatric Acute Myeloid Leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mohammad Faranoush Research Topics

Disease

11	Neoplasms (Cancer) 06/2022 - 01/2007
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2022 - 01/2007
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2021 - 07/2008
3	Hemorrhage 01/2020 - 02/2017
3	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2020 - 12/2008
2	Hematologic Neoplasms (Hematological Malignancy) 02/2022 - 01/2022
2	Leukemia 01/2022 - 02/2019
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2019 - 12/2015
2	Thrombasthenia (Glanzmann Thrombasthenia) 12/2017 - 09/2013
1	Retinoblastoma (Glioblastoma, Retinal) 04/2022
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2015
1	Hemophilia A (Haemophilia) 09/2013
1	Hypersensitivity (Allergy) 06/2013
1	Primary Immunodeficiency Diseases 03/2013
1	Autoimmune Diseases (Autoimmune Disease) 03/2013
1	Oligospermia (Oligozoospermia) 11/2007
1	Azoospermia 11/2007
1	Hodgkin Disease (Hodgkin's Disease) 11/2007
1	Pathologic Processes 01/2007
1	Residual Neoplasm 01/2007

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
3	Inosine Triphosphate (ITP)IBA 01/2020 - 12/2008
2	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2022 - 10/2017
2	EnzymesIBA 02/2022 - 01/2007
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2021
2	Methotrexate (Mexate)FDA LinkGeneric 06/2020 - 01/2020
2	AntigensIBA 07/2008 - 01/2007
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2008 - 01/2007
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 06/2022
1	S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA 06/2022
1	Biological ProductsIBA 02/2022
1	Glutathione Transferase (Glutathione S-Transferase)IBA 02/2022
1	Glutathione (Reduced Glutathione)IBA 02/2022
1	ProteomeIBA 01/2022
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2021
1	IntegrinsIBA 11/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 09/2021
1	LipidsIBA 09/2021
1	PlatinumIBA 09/2021
1	Carbon Nanotubes (Carbon Nanotube)IBA 09/2021
1	BerberineIBA 04/2021
1	AlkaloidsIBA 04/2021
1	isoquinolineIBA 04/2021
1	Interleukin-27 (Interleukin 27)IBA 12/2020
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 02/2019
1	Factor VII (Proconvertin)IBA 01/2019
1	Platelet Membrane Glycoprotein IIbIBA 12/2017
1	DNA (Deoxyribonucleic Acid)IBA 10/2017
1	HirudinsIBA 02/2017
1	Hydroxyurea (Hydrea)FDA LinkGeneric 04/2016
1	Plasminogen Activator Inhibitor 1IBA 12/2015
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2015
1	Plasminogen Activators (Plasminogen Activator)IBA 12/2015
1	Platelet Membrane GlycoproteinsIBA 09/2013
1	Integrin beta3 (GPIIIa)IBA 09/2013
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 09/2013
1	Immunoglobulin E (IgE)IBA 06/2013
1	Intravenous Immunoglobulins (IVIG)FDA Link 12/2008
1	Rho(D) Immune Globulin (RhoGAM)IBA 12/2008
1	Immunoglobulins (Immunoglobulin)IBA 12/2008
1	RHO(D) antibody (anti-D)IBA 12/2008
1	Follicle Stimulating Hormone (Follitropin)FDA Link 11/2007
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 11/2007
1	Testosterone (Sustanon)FDA Link 11/2007
1	Phosphotransferases (Kinase)IBA 01/2007
1	tyrosine receptor (receptor, tyrosine)IBA 01/2007

Therapy/Procedure

5	Therapeutics 11/2021 - 11/2007
2	Drug Therapy (Chemotherapy) 04/2022 - 11/2007
1	Lasers (Laser) 09/2021
1	DAV regimen 12/2015
1	Blood Transfusion (Blood Transfusions) 09/2013
1	Immunotherapy 01/2007